skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Database: Thieme Connect Journals Open Access remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Optimizing Stroke and Bleeding Risk Assessment in Patients with Atrial Fibrillation: A Balance of Evidence, Practicality and Precision
Optimizing Stroke and Bleeding Risk Assessment in Patients with Atrial Fibrillation: A Balance of Evidence, Practicality and Precision
Material Type:
Article 		Add to My Research

Optimizing Stroke and Bleeding Risk Assessment in Patients with Atrial Fibrillation: A Balance of Evidence, Practicality and Precision

Thrombosis and haemostasis, 2018-12, Vol.118 (12), p.2014-2017 [Peer Reviewed Journal]

ISSN: 0340-6245 ;EISSN: 2567-689X ;DOI: 10.1055/s-0038-1676074

Digital Resources/Online E-Resources

Citations Cited by
2
The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation
The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation
Material Type:
Article 		Add to My Research

The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation

Thrombosis and haemostasis, 2021-03, Vol.121 (3), p.270-278 [Peer Reviewed Journal]

Thieme. All rights reserved. ;ISSN: 0340-6245 ;EISSN: 2567-689X ;DOI: 10.1055/s-0040-1716408

Digital Resources/Online E-Resources

Citations Cited by
3
The Challenge of Thromboprophylaxis in Cancer Patients—Balancing the Thrombotic and Bleeding Risks
The Challenge of Thromboprophylaxis in Cancer Patients—Balancing the Thrombotic and Bleeding Risks
Material Type:
Article 		Add to My Research

The Challenge of Thromboprophylaxis in Cancer Patients—Balancing the Thrombotic and Bleeding Risks

Thrombosis and haemostasis, 2018-08, Vol.118 (8), p.1347-1349 [Peer Reviewed Journal]

ISSN: 0340-6245 ;EISSN: 2567-689X ;DOI: 10.1055/s-0038-1667151

Digital Resources/Online E-Resources

Citations Cited by
4
Long-Term Effects of Apixaban Confirmed in the Open-Label Extension of AVERROES Trial
Long-Term Effects of Apixaban Confirmed in the Open-Label Extension of AVERROES Trial
Material Type:
Article 		Add to My Research

Long-Term Effects of Apixaban Confirmed in the Open-Label Extension of AVERROES Trial

Thrombosis and haemostasis, 2021-04, Vol.121 (4), p.405-407 [Peer Reviewed Journal]

Thieme. All rights reserved. ;ISSN: 0340-6245 ;EISSN: 2567-689X ;DOI: 10.1055/a-1367-0184

Digital Resources/Online E-Resources

Citations Cited by
5
Predictors of Adherence to Stroke Prevention in the BALKAN-AF Study: A Machine-Learning Approach
Predictors of Adherence to Stroke Prevention in the BALKAN-AF Study: A Machine-Learning Approach
Material Type:
Article 		Add to My Research

Predictors of Adherence to Stroke Prevention in the BALKAN-AF Study: A Machine-Learning Approach

TH open : companion journal to thrombosis and haemostasis, 2022-07, Vol.6 (3), p.e283-e290 [Peer Reviewed Journal]

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ;The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( ) 2022 The Author(s). ;ISSN: 2512-9465 ;ISSN: 2567-3459 ;EISSN: 2512-9465 ;DOI: 10.1055/s-0042-1755617

Full text available

Citations Cited by
6
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper
Material Type:
Article 		Add to My Research

Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper

Thrombosis and haemostasis, 2022-10, Vol.122 (10), p.1625-1652 [Peer Reviewed Journal]

Thieme. All rights reserved. ;ISSN: 0340-6245 ;EISSN: 2567-689X ;DOI: 10.1055/s-0042-1750385

Digital Resources/Online E-Resources

Citations Cited by
7
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoame
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoame
Material Type:
Article 		Add to My Research

Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoame

Thrombosis and haemostasis, 2017-12, Vol.117 (12), p.2215-2236 [Peer Reviewed Journal]

ISSN: 0340-6245 ;EISSN: 2567-689X ;DOI: 10.1160/TH-17-10-0709

Digital Resources/Online E-Resources

Citations Cited by
8
Idarucizumab for Reversion of Anticoagulant Effect in Daily Practice
Idarucizumab for Reversion of Anticoagulant Effect in Daily Practice
Material Type:
Article 		Add to My Research

Idarucizumab for Reversion of Anticoagulant Effect in Daily Practice

Thrombosis and haemostasis, 2020-01, Vol.120 (1), p.005-007 [Peer Reviewed Journal]

ISSN: 0340-6245 ;EISSN: 2567-689X ;DOI: 10.1055/s-0039-1696646

Digital Resources/Online E-Resources

Citations Cited by
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait